Decitabine-induced effusions

Leukemia Research

Volumn 33, Issue 9, 2009, Pages

  Chen, Chih Cheng ^a,b   Gau, Jyh Pyng ^c,d   You, Jie Yu ^d,e   Lu, Chang Hsien ^a,b   Chan, Chung Huang Hubert ^a,b   Lin, Jen Tsun ^a,b   Lee, Kuan Der ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e LOTUNG POH AI HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMPHOTERICIN B; COLONY STIMULATING FACTOR; IMIPENEM; TEICOPLANIN; THALIDOMIDE;

ADULT; BONE MARROW EXAMINATION; CASE REPORT; DRUG ERUPTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GINGIVA BLEEDING; HEPATITIS C; HUMAN; HUMAN TISSUE; KARYOTYPE 46,XX; LETTER; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; THORACOCENTESIS; THORAX RADIOGRAPHY;

AZACITIDINE; FEMALE; HUMANS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PLEURAL EFFUSION;

EID: 67549112392     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.028     Document Type: Letter

References (4)

1. Kantarjian H., Issa J.P., Rosenfeld C.S., et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106 (2006) 1794-1803
2. Kantarjian H., Oki Y., Garcia-Manero G., et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 109 (2007) 52-57
3. Jayson G.C., Parker G.J., Mullamitha S., et al. Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol 23 (2005) 973-981
4. Quintas-Cardama A., Kantarjian H., O'Brien S., et al. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure. J Clin Oncol 25 (2007) 3908-3914